Joerns Healthcare DermaFloat APL User & Service Manual
User-Service Manual
Joerns® Support Surface
DermaFloat® APL
To avoid injury, read user’s manual before using.
Joerns® Support Surfaces
DermaFloat® APL
Important Precautions
Important Notice: The equipment must be installed
and operated in the manner for which it was intended.
Facility staff/user is responsible for reading and
understanding the product user manual and contacting
Joerns Healthcare, if anything in this manual is
unclear. Joerns will not be held responsible for any
injuries resulting from failure to comply with the
instructions and precautions in this manual.
Warning: Joerns’ specialty support surfaces are
designed as mattress replacement systems. The
risk of entrapment may occur when the equipment is
placed on bed frames that leave gaps of even a few
inches between the mattress and the head panel, foot
panel, and bed or side rails. The equipment is NOT to
be used when such gaps are present.
Facility staff/user is responsible for ensuring that all
mattresses properly t the bed frames. Joerns is not
responsible for the placement of its equipment on bed
frames that leave gaps between the mattress and
the head panel, foot panel or bed or side rails which
present a risk of harm to residents.
Warning: An optimal bed system assessment should
be conducted on each resident by a qualied clinician
or medical provider to ensure maximum safety of
the resident. The assessment should be conducted
within the context of and in compliance with the
state and federal guidelines related to the use of
restraints and bed system entrapment guidance,
including the Clinical Guidance for the Assessment
and Implementation of Side Rails published by the
Hospital Bed Safety Workgroup of the U.S. Food
and Drug Administration. Further information can be
obtained at the following web address: http://www.fda.
gov/MedicalDevices/ProductsandMedicalProcedures/
GeneralHospitalDevicesandSupplies/HospitalBeds/
default.htm.
When using the mattress system, always ensure that
the resident is positioned properly within the connes
of the bed. Do not let any extremities protrude over
the side or between the bed rails when the mattress is
being used.
Danger: Explosion Hazard: Do not use in the
presence of ammable anesthetics. Do not use in
the presence of smoking materials or open ame.
Air owing through the air mattress will support
combustion.
Danger: To reduce the risk of shock, adhere to the
following instructions. Failure to do so could result in
personal injury or equipment damage.
• Immediately after using the DermaFloat® APL,
unplug it from its power source.
• Do not place or store the product where it can fall
or be pulled into a tub or sink.
• Do not place or drop the product into water or
other liquid.
• Do not remove the back of the control unit. Refer
servicing to Joerns.
Warning: To reduce the risk of burns, shock, re, or
personal injury, adhere to the following instructions.
Failure to do so could result in personal injury or
equipment damage.
1. Use this product only for its intended purpose as
described in this manual. Only use attachments
and/or accessories that are recommended by the
manufacturer.
2. If this product has a damaged power cord or plug,
is not working properly, has been dropped or
damaged, or has been dropped into water, do not
operate it. For examination and repair, return the
product to Joerns.
3. Keep the control unit and power cord away from
heated surfaces, e.g. space heaters.
4. Never block the air openings of the product. Do
not place the control unit on a surface, such as a
bed or couch, where the air opening and/or lter
compartment, located on the back of the control
unit, may be blocked. Keep the air openings free
of lint and hair.
5. Never drop or insert any object into any opening
or hose.
6. Do not spill food or liquids onto the control unit. If
a spillage does occur, turn off the unit, disconnect
it from its power supply and allow at least 24 hours
for drying.
7. Do not use the product outdoors, or where
aerosol-spray products are used.
8. Plug this product only into a properly grounded
outlet. Refer to “Grounding Instructions”.
9. Ensure nothing is placed on the power cord and
ensure it is not located where it can be stepped on
or tripped over.
10. Do not attempt to service the control unit. Please
call Joerns for any service requests.
11. The therapy pad (top cover) of this product is not
air permeable and may present a suffocation risk.
It is the responsibility of the caregiver to ensure
that the resident can use this product safely.
2
© 2013 Joerns Healthcare • 6110062 RevE • 13-2625
Joerns® Support Surfaces
DermaFloat® APL
Save These Instructions for Future
Reference
Bed System Entrapment Information
Although essential in the practice of long-term care,
bedside rails, in recent years, have also been a
subject of regulatory review and evolution in design
and use.
That focus includes not only the challenge of
achieving an appropriate balance between resident
security and unnecessary restraint, but also the
additional safety issue of entrapment.
The U.S. Food and Drug Administration (FDA),
working with our company and other industry
representatives has addressed the potential danger
of entrapment with new safety guidelines for medical
beds. These guidelines recommend dimensional
limits for critical gaps and spaces between bed
system components.
Entrapment zones involve the relationship of
components often directly assembled by the
healthcare facility rather than the manufacturer.
Therefore, compliance is the responsibility of the
facility.
Creating a Safer Care Environment
While the guidelines apply to all healthcare settings,
(hospitals, nursing homes and at home), long-term
care facilities have particular exposure since serious
entrapment events typically involve frail, elderly or
dementia patients.
For More Information
To learn more about compliance options with Joerns
products, visit our website at www.joerns.com, or
contact our Customer Care reps at 800-826-0270 and
ask for free informational publications.
To learn more about entrapment zones, assessment
methods and guidelines concerning entrapment,
contact Joerns Healthcare at 800-826-0270 or
consult the FDA website: http://www.fda.gov/
MedicalDevices/ProductsandMedicalProcedures/
GeneralHospitalDevicesandSupplies/HospitalBeds/
default.htm.
As the leading manufacturer of long-term care beds
and a frontrunner in addressing this critical issue,
Joerns Healthcare can offer you the expertise,
assistance and products to bring your facility into
compliance.
Joerns® Compliance Solutions
Matching the right bed components in order to meet
regulatory guidelines can be complex.
That is why Joerns offers a wide array of compliance
options. We assist customers in selecting compliant
accessories recommended for their specic bed
model.
3
© 2013 Joerns Healthcare • 6110062 RevE • 13-2625
Joerns® Support Surfaces
DermaFloat® APL
Table of Contents
Important Precautions ..........................................................................................................................................2
Introduction ............................................................................................................................................................5
Moisture Control
Shear and Friction Reduction
Indications for use .................................................................................................................................................5
Spinal Cord Injury
Pressure Redistribution
Pain Management
Features..................................................................................................................................................................6
Therapy Control Unit Features
Therapy Mattress System Features
Therapy Pads
Grounding Instructions .........................................................................................................................................7
Setup .......................................................................................................................................................................7
Operation ................................................................................................................................................................8
Resident Comfort Controls and Monitoring
Additional Features ............................................................................................................................................... 9
CPR
Transport
Power Failure
CairRails
Optional Accessories
Troubleshooting ....................................................................................................................................................10
Therapy Surface Not Inating
Unable to Change Therapy Mode or Adjust Comfort Control
Nursing Procedures .............................................................................................................................................. 10
Recommended Linen
Changing the Therapy Pad
Resident Positioning and Comfort
Incontinence
Safety Information ................................................................................................................................................. 10
Resident Migration
Traction
Skin Care
Bed Height
Cleaning .................................................................................................................................................................11
Control Unit
General Cleaning
Disinfecting
Therapy Pad
Steam Cleaning
Filter Cleaning
Maintenance ........................................................................................................................................................... 12
Storage and Care ................................................................................................................................................... 12
Control Unit
Support Surface
System Specications ..........................................................................................................................................12
Weight
Dimensions
Electrical Specications
Environmental Conditions
Agency Approvals
Call for Assistance ................................................................................................................................................ 12
Warranty .................................................................................................................................................................14
4
© 2013 Joerns Healthcare • 6110062 RevE • 13-2625
Joerns® Support Surfaces
DermaFloat® APL
Introduction
The DermaFloat® APL, provided by Joerns Healthcare,
is a unique therapy system that provides pressure
redistribution by alternating pressure between adjacent
(A-B) air cells. The alternating pressure in the therapy
cells automatically alternates on a regular basis to
maximize wound healing. Alternating pressure can aid
the healing process by increasing circulation to the
resident’s wounds.
The DermaFloat APL also offers low air loss therapy
through an integrated air delivery system beneath
the therapy pad. Alternating pressure and low air loss
therapy have been demonstrated to be valuable aids
in the treatment of those identied as being at risk of
developing pressure ulcers.
Warning: The risk of entrapment can arise when
equipment is placed on bed frames that leave gaps of
even a few inches between the mattress and the head
panel, foot panel, and bed or side rails. The equipment
is NOT to be used when such gaps are present. See
“Important Precautions” section of this manual.
Moisture Control
Residents are at risk for skin maceration if excess
moisture is permitted to accumulate beneath the
resident. This may be due to perspiration, incontinence
or wound drainage.
On the DermaFloat APL, moisture is controlled via
the specially treated breathable, uid-proof, urethane
coated nylon therapy pad. The moisture vapor
permeable fabric of the therapy pad allows a sufcient
amount of air to circulate beneath the pad and wicks
away excess moisture.
Shear and Friction Reduction
Shearing occurs when the skin is stationary in relation
to the support surface, while the underlying tissues
and vessels are stretched and damaged. When a
resident’s skin rubs against another surface, the result
is friction. The top surface of the DermaFloat APL
therapy pad is constructed from a very smooth nylon
fabric with low friction and low shear properties to
protect the resident’s skin from these damaging forces.
The DermaFloat APL mattress replacement system
is suitable for both the treatment of existing pressure
ulcers Stage I through Stage IV, as well as for
those who have been assessed at risk from the
complications of immobility. The DermaFloat APL
is quiet, comfortable and simple enough for single
caregiver installation, featuring rapid ination in just
15 minutes or less. The user-friendly controls allow for
easy adjustment of resident comfort.
Additionally, low friction and low shear materials,
together with average interface pressures well below
capillary closure levels, means that the DermaFloat
APL meets the comfort and clinical requirements of
your residents up to 350 lbs.
We have ensured that the DermaFloat APL addresses
the four key areas in the treatment of compromised
skin: pressure redistribution, moisture control, and
reduction in both friction and shearing forces.
Indications for Use
Note: The selection of a pressure-redistributing
surface needs to be based on each individual
resident’s clinical condition, diagnosis and/or comorbidities. The choice and use of a support surface
is one factor in a holistic program of wound care and
treatment.
Spinal Cord Injury
The DermaFloat APL is not recommended for use by
residents with unstable spinal fractures. Advice should
be obtained from the appropriate physician before
using the DermaFloat APL system for these residents.
Pressure Redistribution
Pressure Ulcers Rehabilitation
Neurology Dermatology
Burns Amputations
Pain Management
AIDS Arthritis
Oncology
5
© 2013 Joerns Healthcare • 6110062 RevE • 13-2625
Loading...